FDA De Novo Pathway

A blood-draw robot clears the FDA at 1m49s a stick. The missing number is per supervisor

Vitestro's Aletta was authorised through De Novo on 19 August 2026 for supervised outpatient use. The labour it saves per draw is worth about $1.75, so the case has to rest somewhere else.